2,2,2-Trifluoro-1-(1-methyl-4-nitro-1H-pyrrol-2-yl)-ethanone, 95.0%, 5g

2,2',7-Tribromo-9,9'-spirobi[fluorene]>98.0%(HPLC)(T)1g

6-Hydroxy-1,3-dimethylquinazoline-2,4(1H,3H)-dione, 98%, 1g

Methyl 2-((tert-butoxycarbonyl)amino)-2-(4-hydroxyphenyl)acetate, 95%, 5g

1-(2-Hydroxyethyl)-1H-pyrrole-2,5-dione, 95.0%, 5g

5-(2,2,2-Trifluoroethoxy)pyridine-3-carbonitrile, 98%, 100mg

(R)-tert-Butyl 3-(hydroxymethyl)-3,4-dihydroisoquinoline-2(1H)-carboxylate, 95%, 500mg

6-Chloro-3-nitroimidazo[1,2-b]pyridazine, 95.0%, 10g

trans,trans-4-[(E)-1-Propenyl]-4'-propylbicyclohexyl>98.0%(GC)1g

(R)-2-Amino-N-benzyl-3-methoxypropionamide, 95.0%, 100mg

4-Bromo-3-fluoro-2-methylbenzoic acid, 95+%, 1g

2-Bromoethyl 2-methylprop-2-enoate, 95% (stabilized with MEHQ), 100g

1-(Dimethylamino)cyclobutanecarboxylic acid, 98%, 1g